VectivBio Holding AG Ordinary Shares
VECT
VECT was delisted on the 7th of July, 2023.
35 hedge funds and large institutions have $365M invested in VectivBio Holding AG Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
25% more funds holding
Funds holding: 28 → 35 (+7)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
1% less capital invested
Capital invested by funds: $369M → $365M (-$4.41M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$6.43M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.37M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$2.47M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$2.23M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$15.3M |
| 2 |
CA
CHI Advisors
New York
|
-$1.96M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.63M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.42M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$452K |
VECT Hedge Fund Activity: Q1 2023 in Review
35 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q1 2023, worth a combined $365M — down 1.2% from $369M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VECT positions and 2 closed out — a net gain of 7 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was TCG Crossover Management, adding an estimated $6.43M. The largest seller was OrbiMed, cutting an estimated $15.3M.
- 35 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q1 2023, up from 28 in Q4 2022.
- Funds reported $365M of VectivBio Holding AG Ordinary Shares stock for Q1 2023, down 1.2% quarter-over-quarter.
- 9 funds opened new VectivBio Holding AG Ordinary Shares positions in Q1 2023 and 2 closed out, a net change of +7 holders.
- The largest VectivBio Holding AG Ordinary Shares buyer in Q1 2023 was TCG Crossover Management, an estimated $6.43M added.
- The largest VectivBio Holding AG Ordinary Shares seller in Q1 2023 was OrbiMed, an estimated $15.3M sold.
Based on aggregated 13F filings for Q1 2023.